A detailed history of Novo Holdings transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Novo Holdings holds 2,411,362 shares of CORT stock, worth $143 Million. This represents 7.8% of its overall portfolio holdings.

Number of Shares
2,411,362
Previous 2,411,362 -0.0%
Holding current value
$143 Million
Previous $78.3 Million 42.38%
% of portfolio
7.8%
Previous 5.59%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$24.82 - $32.88 $24 Million - $31.8 Million
-966,406 Reduced 28.61%
2,411,362 $78.3 Million
Q4 2022

Feb 14, 2023

BUY
$19.95 - $29.96 $997,500 - $1.5 Million
50,000 Added 1.5%
3,377,768 $68.6 Million
Q3 2022

Nov 14, 2022

BUY
$24.7 - $29.12 $19.8 Million - $23.3 Million
801,278 Added 31.72%
3,327,768 $85.3 Million
Q2 2022

Aug 15, 2022

BUY
$17.33 - $25.3 $43.8 Million - $63.9 Million
2,526,490 New
2,526,490 $60.1 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.34B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.